Back | Next |
home / stock / lctx / lctx message board
Subject | By | Source | When |
---|---|---|---|
NEWS -- Lineage to Present at BTIG Ophthalmology | Paulness | investorshub | 11/29/2022 1:15:06 PM |
NEWS -- Lineage Announces Launch of Phase 2a | Paulness | investorshub | 11/28/2022 1:10:30 PM |
NEWS -- Lineage Cell Therapeutics Reports Third Quarter | Paulness | investorshub | 11/11/2022 2:12:49 AM |
NEWS -- Lineage Cell Therapeutics to Report Third | Paulness | investorshub | 11/03/2022 1:34:33 PM |
and Howe! :-) <3 <3 <3 | chrismiss_everyday | investorshub | 11/01/2022 1:10:34 AM |
NEWS -- Lineage Cell Therapeutics Appoints Jill Howe | Paulness | investorshub | 10/31/2022 1:10:39 PM |
No volume. | abracky | investorshub | 10/10/2022 4:01:26 PM |
NEWS -- Lineage Announces Notice of Allowance of | Paulness | investorshub | 10/10/2022 12:44:44 PM |
NEWS -- Lineage to Present at Alliance for | Paulness | investorshub | 10/04/2022 1:08:50 PM |
NEWS -- Lineage Establishes New R&D Facility in | Paulness | investorshub | 10/03/2022 1:18:11 PM |
https://twitter.com/LineageCell/status/1562424138966663170?s=20&t=i9j9Fm-xWC5w3i | chrismiss_everyday | investorshub | 09/05/2022 8:03:19 PM |
NEWS -- Lineage to Present at H.C. Wainwright | Paulness | investorshub | 08/15/2022 12:23:56 PM |
NEWS -- Lineage Cell Therapeutics, Inc. (LCTX) Q2 | Paulness | investorshub | 08/12/2022 12:45:29 PM |
NEWS -- Lineage Cell Therapeutics to Report Second | Paulness | investorshub | 08/04/2022 12:23:33 PM |
B.Riley Financial Thinks Lineage Cell Therapeutics Stock is | abracky | investorshub | 06/14/2022 10:57:46 AM |
Consistently advancing. Solid groundwork. | chrismiss_everyday | investorshub | 06/02/2022 1:24:00 PM |
NEWS -- Lineage Broadens Collaboration With Advanced BioMatrix | Paulness | investorshub | 06/02/2022 12:17:56 PM |
Lineage Cell Therapeutics Reports First Quarter 2022 Financial | Paulness | investorshub | 05/12/2022 11:02:53 PM |
The primary objective of the study was to | chrismiss_everyday | investorshub | 05/12/2022 1:43:52 PM |
NEWS -- Lineage Cell Therapeutics to Report First | Paulness | investorshub | 05/05/2022 1:14:40 PM |
News, Short Squeeze, Breakout and More Instantly...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company has been added as a member of the broad-market Russell 3000 ® Index, effective after...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company’s CEO, Brian M. Culley, will present at the 2024 BIO International Convention , on Tue...
Persons with Lived Experience Session Expanded to Include Michaela & Kyle Devins Clinical Session Expanded to Include Neuralink Preclinical Session Expanded to Include Axonis, Novoron, Sania & Rewire Medical Lineage Cell Therapeutics, Inc. (NYSE America...